CSL Ltd (CSL)

274.03
+1.03(+0.38%)
  • Volume:
    714,620
  • Bid/Ask:
    273.97/274.03
  • Day's Range:
    270.73 - 274.53

CSL Overview

Prev. Close
273
Day's Range
270.73-274.53
Revenue
15.28B
Open
272.73
52 wk Range
240.1-319.78
EPS
7.31
Volume
714,620
Market Cap
131.58B
Dividend (Yield)
3.0126
(1.10%)
Average Volume (3m)
846,644
P/E Ratio
37.33
Beta
0.43
1-Year Change
-4.96%
Shares Outstanding
481,706,266
Next Earnings Date
Aug 17, 2022
What is your sentiment on CSL?
or
Market is currently closed. Voting is open during market hours.

CSL Ltd News

CSL Ltd Analysis

CSL Ltd Company Profile

CSL Ltd Company Profile

Employees
25000
Market
Australia

CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Its segments include CSL Behring and Seqirus. CSL Behring manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyNeutral
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral